Pfizer's ex-chair and chief executive Ian Read and Frank D'Amelio – previously the drugmaker's finance chief – have issued a ...

Pfizer's former CEO and Chair Ian Read and ex-CFO Frank D'Amelio said in a statement that they will not be involved with ...

Former Pfizer Inc. executives Ian Read and Frank D’Amelio have decided “not to be involved” in Starboard Value’s activist ...

Former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio said they will not be involved with activist investor Starboard Value, ...

The about face comes as the board grapples with the activist's efforts, and just days before Starboard's Jeff Smith was ...

Pfizer (NYSE: PFE) was a stock on the move Wednesday, and not because of any news generated by the healthcare company. Reports of a meeting between Pfizer's leader and an activist investor breathed ...

With Pfizer’s revenue and share price slumping after the drugmaker skyrocketed to new heights during the pandemic, the ...

Health insurance companies are expected to pull back slightly from Medicare Advantage investing in 2025. Instead, Modern Healthcare reports, they will focus on Dual-Eligible Special Needs Plans, or ...

Pfizer CEO Albert Bourla reportedly is planning to meet with Starboard Value after the activist investor took a $1 billion ...

Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...

Pfizer Inc. CEO Albert Bourla is set to meet with activist investor Starboard Value amid growing pressure to revitalize the ...

Guggenheim Securities, LLC is issuing a statement on behalf of former Pfizer CEO Ian Read and former Pfizer CFO Frank D’Amelio: We have decided not to be involved n the efforts of Starboard Value ...